CLXT stock surges on merger with gene editing company Cibus (NASDAQ:CLXT)

word m and a made with wood building blocks, stock image

Maksim Labkouski

The shares of plant-based artificial biology company Calyxt, Inc. (NASDAQ:CLXT) climbed ~88% pre-market Tuesday after saying a merger settlement with Cibus, an agricultural expertise company targeted on plant-based gene editing.

“Cibus is a wonderful strategic match for Calyxt givenCLXT

Source link

5 Trading strategies to make money

Looking to boost your trading profits?

Get you copy of our FREE Ebook Now !!!